Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us 
About
Not Confirmed
Not Confirmed
24-26 February, 2026
Not Confirmed
Not Confirmed
17-21 January, 2026
Not Confirmed
Not Confirmed
21-22 January, 2026
List your booth number for exhibitions, ask us 
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Tides Asia
Not Confirmed
Contact SupplierTides Asia
Industry Trade Show
Not Confirmed
24-26 February, 2026
Industry Trade Show
Not Confirmed
17-21 January, 2026
Industry Trade Show
Not Confirmed
21-22 January, 2026
Digital content
NEWS #PharmaBuzz
30 Mar 2023
// RAPS
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/ingredion-open-for-acquisitions-partnerships-in-india-to-expand-business/articleshow/99120938.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
Drugs in Development
Details:
Starch is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Hyperglycemia.
Lead Product(s): Starch
Therapeutic Area: Endocrinology Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Plant Extract/Herbal
Recipient: Purdue University
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable June 11, 2014
Lead Product(s) : Starch
Therapeutic Area : Endocrinology
Highest Development Status : Undisclosed
Recipient : Purdue University
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of Resistant Starch in a Beverage on Post-prandial Glycemic and Insulinemic Responses
Details : Starch is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Hyperglycemia.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
June 11, 2014
Details:
SC-FOS is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Constipation.
Lead Product(s): SC-FOS
Therapeutic Area: Gastroenterology Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Probiotic
Recipient: NIZO Food Research
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable May 16, 2014
Lead Product(s) : SC-FOS
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Recipient : NIZO Food Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Trial on Short-chain Fructooligosaccharides, Microbiota, and Constipation in Adults
Details : SC-FOS is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Constipation.
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
May 16, 2014
Details:
Dietary Fiber is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Lead Product(s): Dietary Fiber
Therapeutic Area: Undisclosed Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Dietary Supplement
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable January 31, 2012
Lead Product(s) : Dietary Fiber
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of Dietary Fiber on Insulin Sensitivity
Details : Dietary Fiber is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
January 31, 2012
Details:
Dietary Fiber is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Lead Product(s): Dietary Fiber
Therapeutic Area: Undisclosed Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Dietary Supplement
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable January 25, 2012
Lead Product(s) : Dietary Fiber
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of a Dietary Fiber on Fecal Microbiota and Metabolism
Details : Dietary Fiber is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
January 25, 2012
Details:
Dietary Fiber is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Lead Product(s): Dietary Fiber
Therapeutic Area: Undisclosed Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Dietary Supplement
Recipient: Clinical Nutrition Research Center, Illinois Institute of Technology
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable December 22, 2011
Lead Product(s) : Dietary Fiber
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Recipient : Clinical Nutrition Research Center, Illinois Institute of Technology
Deal Size : Inapplicable
Deal Type : Inapplicable
Assessing Fermentability of a Dietary Fiber
Details : Dietary Fiber is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
December 22, 2011
Details:
Starch is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Lead Product(s): Starch
Therapeutic Area: Undisclosed Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Plant Extract/Herbal
Recipient: Clinical Nutrition Research Center, Illinois Institute of Technology
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable May 19, 2010
Lead Product(s) : Starch
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Recipient : Clinical Nutrition Research Center, Illinois Institute of Technology
Deal Size : Inapplicable
Deal Type : Inapplicable
Types of Resistant Starch and Their Effect on Appetite
Details : Starch is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
May 19, 2010
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients
All Excipients
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
Click Us!
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15712
Submission : 2001-11-12
Status : Active
Type : IV
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16190
Submission : 2002-10-15
Status : Active
Type : IV
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35818
Submission : 2021-05-06
Status : Active
Type : IV
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10911
Submission : 1994-05-13
Status : Active
Type : IV
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15713
Submission : 2001-11-12
Status : Inactive
Type : IV
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16103
Submission : 2002-08-21
Status : Inactive
Type : IV
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16257
Submission : 2002-11-21
Status : Inactive
Type : IV
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Products
Dosage Form : Tablet
Grade : Oral
Application : Disintegrants & Superdisintegrants, Rheology Modifiers
Excipient Details : Croscarmellose Sodium, Cellulose is used as a superdisintegrant and rheology modifier in oral dosage forms such as tablets.
Dosage Form : Tablet
Grade : Oral
Application : Fillers, Diluents & Binders
Excipient Details : Mannitol is used as a filler and binder in the manufacturing of oral solid dosage forms such as tablets.
Dosage Form : Tablet
Grade : Oral
Application : Disintegrants & Superdisintegrants
Excipient Details : Sodium Starch Glycolate, Potato is used as a superdisintegrant in the oral dosage forms such as tablets.
Dosage Form : Emulsion
Grade : Oral, Topical
Application : Thickeners and Stabilizers
Excipient Details : Modified Starch, Corn is a white powder and a unique emulsion stabilising starch derived from waxy maize.
Dosage Form : Tablet
Grade : Oral
Application : Fillers, Diluents & Binders, Granulation
Excipient Details : Fully Pregel Starch Corn is used as a binder in wet granulation in the manufacturing of tablets.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Ingredients
Starch
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Croscarmellose Sodium
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sodium Starch Glycolate
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Mannitol
Dosage Form : Tablet
Grade : Oral
Application : Fillers, Diluents & Binders
Excipient Details : Mannitol is used as a filler and binder in the manufacturing of oral solid dosage forms such as tablets.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients By applications
Disintegrants & Superdisintegrants
Dosage Form : Tablet
Grade : Oral
Application : Disintegrants & Superdisintegrants, Rheology Modifiers
Excipient Details : Croscarmellose Sodium, Cellulose is used as a superdisintegrant and rheology modifier in oral dosage forms such as tablets.
Dosage Form : Tablet
Grade : Oral
Application : Disintegrants & Superdisintegrants
Excipient Details : Sodium Starch Glycolate, Potato is used as a superdisintegrant in the oral dosage forms such as tablets.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Granulation
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Rheology Modifiers
Dosage Form : Tablet
Grade : Oral
Application : Disintegrants & Superdisintegrants, Rheology Modifiers
Excipient Details : Croscarmellose Sodium, Cellulose is used as a superdisintegrant and rheology modifier in oral dosage forms such as tablets.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Thickeners and Stabilizers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Inspections and registrations
FDA
District Decision : No Action Indicated
Inspection End Date : 2017-09-29
City : Westchester
State : IL
Country/Area : U.S.A
Zip : 60154-5749
District : CHI
Center : CFSAN
Project Area : Foodborne Biological Hazards
District Decision : No Action Indicated
Inspection End Date : 2017-09-29
District Decision : Voluntary Action Indicated
Inspection End Date : 2015-07-01
City : Bedford Park
State : IL
Country/Area : U.S.A
Zip : 60501-1935
District : CHI
Center : CDER
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2015-07-01
District Decision : No Action Indicated
Inspection End Date : 2012-07-26
City : Indianapolis
State : IN
Country/Area : U.S.A
Zip : 46221-2010
District : DET
Center : CFSAN
Project Area : Foodborne Biological Hazards
District Decision : No Action Indicated
Inspection End Date : 2012-07-26
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]GDUFA
API Manufacturer : API MANUFACTURE
FDF Manufacturer :
Facility Name : Ingredion Incoporated
Business Address : 6400 S Archer Ave Bedford Pa...
FEI Number : 3010087769
Country : U.S.A
Paid in : 2019
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
Ingredion Pharma Solutions is a supplier offers 3 products (APIs, Excipients or Intermediates).
Find a price of Glucose bulk with DMF offered by Ingredion Pharma Solutions
Find a price of Mannitol API bulk offered by Ingredion Pharma Solutions
Find a price of GLUCURONO-LACTONE $ THE SALTS OF GLUCURONIC ACID bulk offered by Ingredion Pharma Solutions
Share 
